EFFECTIVENESS AND SAFETY OF PLATINUM BASED AGENTS NEOADJUVANT CHEMOTHERAPY ON PATHOLOGICAL COMPLETE RESPONSE IN TRIPLE NEGATIVE BREAST CANCER PATIENTS (A RETROSPECTIVE STUDY)

Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine as First-Line Therapy for Metastatic Triple Negative Breast Cancer

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGICAL DATA AND OUTCOMES OF HORMONAL POSITIVE HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAM

RESPONSE OF LOCALY ADVANCED BREAST CANCER TO PRIMARY CHEMOTHERAPY; IS IT ELIGIBLE FOR BREAST CONSERVATION

Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer

The validity of giving adjuvant capecitabine after standard anthracycline and/or taxanes based neo-/adjuvant chemotherapy in early triple-negative breast cancer patients: An Egypt

A retrospective study of the effect of neoadjuvant chemotherapy as a primary treatment of advanced breast cancer and its effect on surgical modalities.

Assessment Study in Breast Conservative surgery in Locally Advanced Breast Cancer after Good Response to Neoadjuvant Chemotherapy

RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER